Shijie Li Selected Research

Sorafenib (BAY 43-9006)

2/2021	Adjuvant transarterial chemoembolization to sorafenib in unresectable hepatocellular carcinoma: A meta-analysis.
1/2019	Polymer Nanoformulation of Sorafenib and All-Trans Retinoic Acid for Synergistic Inhibition of Thyroid Cancer.
1/2015	Interaction of key pathways in sorafenib-treated hepatocellular carcinoma based on a PCR-array.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shijie Li Research Topics

Disease

47	Neoplasms (Cancer) 05/2024 - 10/2012
11	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 10/2012
8	Gallbladder Neoplasms (Gallbladder Cancer) 02/2024 - 01/2020
7	Thyroid Neoplasms (Thyroid Cancer) 01/2022 - 01/2017
6	Wounds and Injuries (Trauma) 12/2023 - 06/2018
6	Inflammation (Inflammations) 02/2023 - 01/2013
6	Neoplasm Metastasis (Metastasis) 01/2023 - 11/2017
5	Carcinoma (Carcinomatosis) 01/2023 - 10/2013
5	Insulin Resistance 01/2020 - 02/2010
4	Alzheimer Disease (Alzheimer's Disease) 06/2023 - 01/2020
4	Lymphatic Metastasis 01/2023 - 01/2020
4	Stomach Neoplasms (Stomach Cancer) 01/2022 - 02/2021
4	Thrombosis (Thrombus) 01/2021 - 02/2015
3	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 01/2013
3	Burns 02/2024 - 01/2018
3	Cicatrix (Scar) 12/2023 - 08/2020
3	Body Weight (Weight, Body) 09/2023 - 01/2020
3	Circulating Neoplastic Cells 09/2023 - 01/2023
3	Glioma (Gliomas) 03/2023 - 01/2022
3	Coronary Disease (Coronary Heart Disease) 02/2023 - 01/2021
3	Fibrosis (Cirrhosis) 02/2022 - 10/2020
3	Osteosarcoma (Osteogenic Sarcoma) 01/2018 - 07/2016
2	Urinary Bladder Neoplasms (Bladder Cancer) 05/2024 - 01/2021
2	Pain (Aches) 05/2024 - 05/2017
2	Hypertrophy 03/2024 - 04/2006
2	Heart Failure 03/2024 - 05/2019
2	Weight Loss (Weight Reduction) 12/2023 - 04/2018
2	Asthma (Bronchial Asthma) 11/2023 - 12/2021
2	Anemia 10/2023 - 01/2022
2	Mitochondrial Diseases (Mitochondrial Disease) 06/2023 - 11/2020
2	Hypoxia (Hypoxemia) 11/2021 - 10/2020
2	Vomiting 01/2021 - 05/2017
2	Nausea 01/2021 - 05/2017
2	Colitis 04/2018 - 02/2018
2	Colorectal Neoplasms (Colorectal Cancer) 11/2017 - 01/2016
2	Perinatal Death 04/2007 - 02/2005
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 05/2024
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2024
1	Autoimmune Diseases (Autoimmune Disease) 04/2024
1	Chronic Hepatitis B 04/2024

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 09/2023 - 03/2012
10	Biomarkers (Surrogate Marker)IBA 02/2023 - 10/2012
5	Polysaccharides (Glycans)IBA 04/2023 - 02/2018
4	LipidsIBA 04/2024 - 08/2019
4	AntigensIBA 04/2024 - 05/2017
4	CytokinesIBA 02/2023 - 01/2016
4	MicroRNAs (MicroRNA)IBA 01/2023 - 11/2017
4	AlbuminsIBA 11/2021 - 01/2019
3	Cisplatin (Platino)FDA LinkGeneric 05/2024 - 01/2021
3	Monoclonal AntibodiesIBA 04/2024 - 01/2023
3	Peptides (Polypeptides)IBA 03/2024 - 01/2019
3	CollagenIBA 12/2023 - 01/2022
3	Cell-Free Nucleic AcidsIBA 09/2023 - 01/2023
3	Circular RNAIBA 03/2023 - 01/2021
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 02/2005
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 02/2010
3	Sorafenib (BAY 43-9006)FDA Link 02/2021 - 01/2015
3	Insulin (Novolin)FDA Link 10/2019 - 02/2010
3	Messenger RNA (mRNA)IBA 01/2019 - 10/2013
2	AntibodiesIBA 04/2024 - 01/2013
2	Metal-Organic FrameworksIBA 02/2024 - 05/2023
2	Serum AlbuminIBA 02/2024 - 01/2021
2	Blood Glucose (Blood Sugar)IBA 02/2024 - 10/2019
2	Therapeutic UsesIBA 12/2023 - 03/2023
2	LigandsIBA 11/2023 - 01/2017
2	GoldIBA 11/2023 - 02/2021
2	Amyloid (Amyloid Fibrils)IBA 06/2023 - 11/2020
2	Apolipoproteins E (ApoE)IBA 04/2023 - 11/2019
2	Circulating Tumor DNAIBA 04/2023 - 01/2023
2	Interleukin-6 (Interleukin 6)IBA 02/2023 - 12/2021
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2023
2	Fibrinogen (Factor I)FDA Link 01/2022 - 01/2022
2	Indicators and Reagents (Reagents)IBA 01/2021 - 02/2018
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2020 - 04/2018
2	Photosensitizing Agents (Photosensitizers)IBA 01/2020 - 10/2018
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2020 - 01/2019
2	Long Noncoding RNAIBA 01/2020 - 01/2019
2	egg-oilIBA 01/2020 - 10/2019
2	VaccinesIBA 05/2017 - 03/2012
2	CateninsIBA 01/2017 - 07/2016
2	Histones (Histone)IBA 10/2014 - 10/2012
2	Histone Deacetylases (Histone Deacetylase)IBA 10/2012 - 04/2006
1	artenimol (dihydroartemisinin)IBA 05/2024
1	incobotulinumtoxinA FDA Link 05/2024
1	Type A Botulinum Toxins (Botox)FDA Link 05/2024
1	flumatinibIBA 04/2024
1	Peptide Hydrolases (Proteases)FDA Link 04/2024
1	Immunoconjugates (Immunoconjugate)IBA 04/2024
1	DNA (Deoxyribonucleic Acid)IBA 04/2024
1	Hepatitis B e AntigensIBA 04/2024
1	Surface Antigens (Surface Antigen)IBA 04/2024
1	MucinsIBA 03/2024

Therapy/Procedure

19	Therapeutics 04/2024 - 01/2013
5	Drug Therapy (Chemotherapy) 01/2023 - 01/2017
3	Immunotherapy 04/2024 - 01/2023
3	Photochemotherapy (Photodynamic Therapy) 01/2023 - 10/2018
3	Stents 04/2022 - 01/2021
2	Nephrectomy 01/2022 - 02/2015
2	Precision Medicine 01/2021 - 10/2018
1	Injections 05/2024